In addition, M344 specifically enhanced SMN2 exon 7 inclusion in primary fibroblasts from SMA patients [37], and was proposed to act via upregulation of protein expression of the SR-like splicing factor human transformer 2, beta 1 (Htra2-β1). Here, SMN2 is linked to proximal spinal muscular atrophy.